The BeyondAir LungFit iNO System in Canada: A Comprehensive Guide to Cylinder-Free Nitric Oxide Therapy

Discover how the BeyondAir LungFit PH iNO system is revolutionizing Canadian respiratory care by generating unlimited inhaled nitric oxide from ambient air.

In the high-stakes environment of neonatal and adult critical care, the reliable delivery of inhaled nitric oxide (iNO) can be a life-saving intervention. For decades, Canadian hospitals have depended on a complex and cumbersome system of high-pressure gas cylinders to administer this therapy. This traditional model, however, is fraught with logistical challenges, supply chain vulnerabilities, and unpredictable costs. Today, a paradigm shift is underway, moving iNO delivery from a volatile logistics challenge to a stable, on-demand clinical utility. The catalyst for this transformation is the LungFit iNO system, a cylinder-free solution that generates medical-grade nitric oxide directly at the point of care.

Brought to Canadian healthcare facilities by Novus Medical Inc., the LungFit PH system represents a significant advancement in respiratory technology. By producing iNO from ambient air, it eliminates the need for heavy cylinders, streamlines clinical workflows, and provides hospitals with unprecedented budget certainty and supply chain resilience. This guide offers a comprehensive overview for Canadian respiratory therapists, clinical leads, and hospital administrators on how this innovative technology works and the strategic advantages it offers.

Modernizing Inhaled Nitric Oxide Therapy in Canadian Healthcare

Inhaled nitric oxide is a critical tool for treating pulmonary hypertension in both neonatal and adult patients, acting as a selective pulmonary vasodilator to improve oxygenation and reduce the need for more invasive interventions. While its clinical value is undisputed, the traditional delivery method has long been a source of operational friction within Canadian hospitals.

The Limitations of Traditional iNO Delivery

The conventional cylinder-based model presents several inherent challenges that impact efficiency, safety, and cost:

• Complex Logistics: Managing an inventory of heavy, high-pressure gas cylinders requires significant administrative and physical effort. This includes ordering, receiving, transporting within the hospital, storing in specialized facilities, and returning used tanks.
• Manual Handling and Safety Risks: The sheer weight and size of iNO cylinders pose a risk of musculoskeletal injury to clinical and support staff during transport and setup.
• Gas Waste and Inefficiency: A significant amount of expensive nitric oxide gas is often left as residual pressure in cylinders that are deemed "empty," leading to considerable waste and financial loss over time.  Alternatively, therapists have been known to forget to turn off the cylinder, causing hospitals to pay for gas they never used.
• Supply Chain Vulnerability: Dependence on external gas suppliers and delivery schedules exposes hospitals to potential disruptions, a risk that was starkly highlighted during recent global supply chain crises.

Why In-Hospital Generation is the Future

The LungFit iNO system directly addresses these limitations by shifting the production of nitric oxide to the patient’s bedside. This technology-driven model offers a more sustainable and efficient future for respiratory care in Canada.

• Unmatched Reliability: By using ambient air—a limitless and free raw material—the system ensures a continuous, uninterrupted supply of iNO, completely independent of external gas deliveries.
• Optimized Clinical Space: Eliminating bulky cylinders frees up valuable space in crowded Neonatal Intensive Care Units (NICUs) and Intensive Care Units (ICUs), creating a safer and more organized care environment. The LungFit can be placed, out of the way, to the back of the bedside.
• Operational Simplicity: The transition from a logistics-heavy supply chain to a self-contained technology simplifies inventory management, reduces administrative overhead, and allows clinical staff to focus more on patient care.

How Plasma Pulse Technology™ Generates iNO from Ambient Air

At the core of the LungFit iNO system is its patented Plasma Pulse Technology™, a groundbreaking method for creating nitric oxide without the need for compressed gas. This innovative process is not only effective but also remarkably efficient and safe, providing clinicians with the precision they require and the reliability hospitals demand.

The system works by drawing in ambient air, which is primarily composed of nitrogen (N₂) and oxygen (O₂). Inside the generator, a series of controlled electrical discharges—or plasma pulses—are applied to this air. These pulses have enough energy to break the strong molecular bonds of N₂ and O₂, allowing the nitrogen and oxygen atoms to recombine and form nitric oxide (NO). The entire process is meticulously controlled to produce a precise concentration of therapeutic gas, which is then delivered to the patient’s ventilator circuit.

Key features of this technology include:

• Precision and Control: The system generates iNO on demand, ensuring that only the amount needed for the prescribed dose is produced.
• Built-in Safety Monitoring: Multiple internal sensors continuously monitor the gas output, ensuring purity and concentration accuracy while guarding against the formation of impurities.
• Exceptional Energy Efficiency: The LungFit PH generator operates with remarkable efficiency, consuming an amount of power equivalent to a standard 60-watt light bulb, allowing it to be used with standard hospital electrical outlets without placing a strain on power systems.

Precision Delivery and Dose Monitoring

Clinical confidence is paramount in iNO therapy. The LungFit iNO system is engineered to deliver precise doses ranging from 0.1 to 80 parts per million (ppm), accommodating a wide spectrum of clinical needs. To ensure accuracy and patient safety, the system incorporates a dual-channel monitoring system. This redundancy provides continuous, independent verification of both NO and nitrogen dioxide (NO₂) levels, giving respiratory therapists and physicians complete confidence in the therapy being delivered. Automated alerts notify clinicians of filter change requirements and other system status updates, ensuring proactive management.

The Role of the NO₂ Smart Filter

A critical component of the system’s safety architecture is the NO₂ Smart Filter. Nitrogen dioxide (NO₂) is a potential toxic byproduct that can form when nitric oxide mixes with oxygen. The LungFit system is designed to minimize NO₂ formation, and the Smart Filter serves as a crucial final safeguard. It effectively scrubs the delivered gas to remove any trace amounts of NO₂, protecting the patient from potential airway inflammation or injury. Each filter has a predictable 12-hour lifespan, which simplifies consumables management by allowing RTs to coordinate filter changes with routine ventilator checks and other scheduled tasks, further streamlining the clinical workflow.

Comparing Traditional Cylinders to the LungFit iNO System

For hospital administrators and procurement officers in Canada, the decision to adopt new technology hinges on a clear analysis of its operational and financial impact. The LungFit iNO system offers compelling advantages over the traditional cylinder model across logistics, cost, and risk mitigation.

A direct comparison reveals a stark contrast:

• Total Cost of Ownership: Cylinder-based therapy involves numerous hidden costs, including cylinder rental fees, delivery charges, hazmat fees, administrative overhead for inventory management, and the cost of wasted gas. The LungFit system, offered through an all-inclusive contract, consolidates these variable expenses into a single, predictable annual cost.
• Logistical Footprint: The LungFit system eliminates the entire infrastructure associated with medical gas cylinders. This means no more dedicated storage rooms, no complex internal transport protocols, and no staff time spent managing tank inventory.
• Waste Reduction: By generating iNO on demand, the system produces only what is needed for the patient. This 100% utilization model completely eliminates the financial losses associated with residual gas left in "empty" cylinders.
• Speed and Efficiency: In critical situations, time is of the essence. The LungFit PH system is designed for rapid deployment, enabling a respiratory therapist to initiate iNO therapy in under one minute—a significant improvement over the multi-step process of locating, transporting, and connecting a heavy gas cylinder.

Supply Chain Resilience and Risk Mitigation

The ability to generate iNO from ambient air fundamentally changes a hospital’s risk profile. This on-demand model provides an unprecedented level of supply chain resilience, a critical consideration for Canadian healthcare facilities, particularly those in remote or hard-to-reach locations.

• Independence from Suppliers: The system severs the dependency on third-party medical gas manufacturers and their delivery schedules, insulating the hospital from supplier shortages, transportation strikes, or logistical failures.
• Continuity of Care: The risk of a critical therapy being interrupted because a cylinder runs empty unexpectedly is completely eliminated. The LungFit system provides a truly unlimited supply of iNO, available 24/7.
• Pandemic and Surge Preparedness: During public health emergencies or seasonal surges in patient volume, the demand for iNO can spike unpredictably. An on-site generation system ensures a hospital can scale its iNO therapy capacity instantly without needing to arrange emergency gas deliveries.

Budget Certainty in Canadian Procurement

For hospital finance and procurement departments, the LungFit iNO system, supported by Novus Medical’s all-inclusive service model, transforms iNO therapy from a volatile operational expense into a predictable, fixed cost.

• Capital purchase: Hospitals can move away from the ever inflating fixed annual cost, and purchase the LungFit PH outright, and the paying for the consumables on a per patient basis.  Now users know what they are paying for.
• **Fixed Annual Cost: **A fixed annual contract option is also available and covers the device, all consumables, maintenance, and technical support, allowing for precise and confident budget planning.
• Simplified Financial Planning: The capital purchase model and all-inclusive model provide flexibility to manage operational and capital costs as each institution see fit.
• Reduced Administrative Burden: By eliminating the need to track cylinder inventory, manage rental agreements, and process invoices from multiple vendors, the system significantly reduces the administrative workload on both clinical and financial staff.

Integrating LungFit PH into the Clinical Workflow

Technology is only as effective as its adoption by frontline clinicians. The LungFit PH was designed with the end-user in mind, featuring a compact, intuitive design that integrates seamlessly into the fast-paced and space-constrained environments of the NICU and ICU.

The generator itself is remarkably small and lightweight, easily mounted on a ventilator cart or IV pole, preserving critical space around the patient’s bedside. Its user interface is designed to be familiar and straightforward, minimizing the learning curve for respiratory therapists and reducing the risk of user error. This flexibility allows the LungFit PH to be deployed across various care settings, from neonatal incubators to adult critical care beds, providing a standardized iNO delivery platform throughout the hospital.

Streamlining the Respiratory Therapist Workflow

The LungFit iNO system provides tangible benefits that make the demanding job of a respiratory therapist (RT) more efficient and focused on patient care.

• Eliminating Cylinder-Related Tasks: RTs can reclaim significant time previously spent on non-clinical tasks such as locating, transporting, and swapping heavy cylinders, as well as conducting laborious inventory checks.
• Rapid Therapy Initiation: The simplified setup, involving just three connections, allows for the rapid start of therapy, a crucial advantage in emergent clinical situations.
• Coordinated Consumables Management: The 12-hour lifecycle of the NO₂ Smart Filter is designed to align with standard 12-hour nursing and RT shifts, allowing filter changes to be bundled with routine ventilator and patient assessments.
• Auto Purge: The system auto-purges the iNO delivery lines, when ever therapy has been stopped or paused, eliminating the chances of forgetting to purge the system, and inadvertently delivering NO2 to the patient.

Patient Transport and Mobility

Ensuring the continuity of iNO therapy during intra-hospital transport is a major logistical challenge with cylinder-based systems. The LungFit PH offers a superior solution for patient mobility.

• Lightweight Portability: The compact generator is significantly lighter and less cumbersome than even the smallest D-sized medical gas cylinders, making it easier and safer to manage during transport.
• Battery-Powered Operation: The system is equipped with a battery that provides ample power for moving patients between units, to diagnostic imaging suites, or to the operating room, all without interrupting therapy.
• Uninterrupted Therapeutic Delivery: This seamless portability ensures that the prescribed dose of iNO is maintained throughout the transport process, safeguarding the patient’s stability during critical moves.

Partnering with Novus Medical for iNO Excellence

Adopting transformative technology requires more than just innovative hardware; it demands a dedicated partner committed to clinical success. Novus Medical is the exclusive Canadian distributor for the LungFit PH system, providing a comprehensive support infrastructure to ensure a smooth transition and ongoing operational excellence for hospitals across the country.

Choosing the LungFit iNO system through Novus Medical means gaining a long-term clinical partner, not just a vendor. This partnership includes:

• A National Service Network: With technical support professionals located across Canada, Novus Medical provides prompt, reliable service and maintenance, ensuring maximum uptime for your equipment.
• Comprehensive Training: Novus Medical offers in-depth training programs for respiratory therapists, biomedical technicians, and other clinical staff to ensure they are confident and proficient in operating the system.
• Customized Service Agreements: Understanding that every hospital has unique needs, Novus Medical works with procurement teams to develop customized, all-inclusive contracts that align with specific budgetary and operational requirements.

Comprehensive Support and Maintenance

Novus Medical’s commitment extends throughout the entire lifecycle of the LungFit iNO system. The national support network provides authorized technical repairs and fulfills all warranty obligations, giving hospitals peace of mind. Annual service agreements are designed to ensure the longevity and peak performance of each device, while access to clinical specialists provides a valuable resource for ongoing education and troubleshooting complex cases.

Next Steps for Canadian Hospital Administrators

For Canadian hospitals looking to modernize their iNO therapy, enhance patient safety, and achieve greater financial predictability, the first step is to connect with Novus Medical. Their team of clinical and technical experts can provide a detailed cost-benefit analysis tailored to your facility’s specific iNO usage and logistical costs. They will guide you through the process of transitioning from a cylinder-based model to the LungFit iNO system, ensuring a seamless and well-supported implementation.

Frequently Asked Questions (FAQs)

**Is the LungFit iNO system Health Canada approved?

**
Yes, the LungFit PH system has received Health Canada approval for the treatment of term and near-term neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension.

**How does the LungFit system generate nitric oxide without cylinders?

**
The system uses patented Plasma Pulse Technology™ to convert nitrogen and oxygen from ambient room air into medical-grade nitric oxide. A series of controlled electrical pulses create a plasma field that breaks down air molecules and allows them to reform as nitric oxide at a precise concentration.

**What are the cost benefits of moving to a cylinder-free iNO system?

**
The primary cost benefits are achieving reducing operating budgets, eliminating the costs of wasted gas in "empty" cylinders, or charges for gas not used, and reducing the administrative and labour costs associated with managing cylinder inventory, storage, and transport.

**Can the LungFit system be used during patient transport within the hospital?

**
Absolutely. The LungFit PH is lightweight, compact, and features a battery, making it ideal for intra-hospital transport. It ensures continuous, uninterrupted iNO therapy as patients are moved between the ICU, NICU, operating rooms, or diagnostic imaging centres.

**What kind of maintenance does the LungFit iNO system require?

**
Routine maintenance is minimal and primarily involves the scheduled replacement of the NO₂ Smart Filter every 12 hours. Novus Medical provides comprehensive annual preventative maintenance and technical support as part of its all-inclusive or a-la-carte service agreements.

**How long does it take to set up the LungFit PH system in an emergency?

**
The system is designed for rapid deployment. A trained respiratory therapist can typically complete the setup, which involves just three simple connections, and initiate iNO therapy in under one minute.

**Does the system require specialized electrical outlets or high power?

**
No, the LungFit iNO system is highly energy-efficient, consuming about the same amount of power as a 60-watt light bulb. It plugs into any standard hospital-grade electrical outlet and does not require specialized wiring.

**How does the NO₂ Smart Filter ensure patient safety?

**
The NO₂ Smart Filter is a critical safety component that scrubs the gas immediately before it is delivered to the patient. It removes any trace amounts of nitrogen dioxide (NO₂), a potential toxic byproduct, ensuring the purity of the therapy and protecting the patient’s airways.

To learn more about how the LungFit iNO system in Canada can enhance your hospital’s respiratory care program while reducing costs and improving supply chain resilience, contact the experts at Novus Medical today.

Contact Novus Medical for a LungFit PH Cost-Benefit Analysis